Ifenprodil and SL 82.0715 antagonize N-methyl-D-aspartate (NMDA)-coupled glycine receptor responses in vivo.
Rao
T S
TS
CNS Diseases Research, G.D. Searle & Co., St. Louis, MO 63198.
Cler
J
J
Emmett
M R
MR
Mick
S
S
Iyengar
S
S
Contreras
P C
PC
Wood
P L
PL
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002531:Cerebellum / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D007267:Injections; D008297:Male; D051379:Mice; D010880:Piperidines / Q000494:pharmacology*; D017459:Receptors, Amino Acid; D011956:Receptors, Cell Surface / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D012694:Serine / Q000494:pharmacology; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D010880:Piperidines; D017459:Receptors, Amino Acid; D011956:Receptors, Cell Surface; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D012694:Serine; D006152:Cyclic GMP; C010739:ifenprodil; D005998:Glycine; C058083:eliprodil